Northrop Grumman CORP /DE/ 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Northrop Grumman announced record backlog and increased 2026 financial guidance for sales and EPS following a 5% year-over-year sales increase in the second quarter.
NYSE
Northrop Grumman Corporation's 2026 Annual Meeting saw shareholders overwhelmingly approve management's proposals, including director elections and auditor ratification, while rejecting a shareholder proposal for an independent board chair.
NYSE
Northrop Grumman reported strong first quarter 2026 financial results, with sales up 4% and EPS significantly increasing, driven by robust demand and strategic agreements.
NYSE
Northrop Grumman Corporation announced the election of Admiral Christopher W. Grady to its Board of Directors, alongside changes in executive compensation metrics and lead independent director.
NYSE
Northrop Grumman reported a 10% sales increase in Q4 2025 and 2% for the full year, with record backlog and positive 2026 guidance.
NYSE
Northrop Grumman Corporation announced the election of John Greene as its new Chief Financial Officer, effective January 7, 2026, succeeding Ken Crews.
NYSE
Northrop Grumman reported strong third quarter 2025 financial results with sales up 4% to $10.4 billion and diluted EPS increasing 10% to $7.67, leading to an upward revision of its full-year 2025 EPS guidance.
NYSE
Northrop Grumman Corporation has entered into a new five-year senior unsecured revolving credit facility totaling $3 billion, replacing its previous $2.5 billion facility.
NYSE
Northrop Grumman reported a 1% increase in second-quarter 2025 sales to $10.4 billion and a 25% rise in net earnings to $1.2 billion, leading to an upward revision of its full-year financial guidance.
NYSE
Northrop Grumman Corporation has completed a $1 billion debt offering, issuing senior notes due in 2030 and 2035 to manage its capital structure and fund general corporate purposes.
NYSE
Northrop Grumman Corporation announced the pricing of a $1.0 billion underwritten public offering of senior unsecured notes, with proceeds intended for general corporate purposes including debt repayment and share repurchases.
NYSE
Northrop Grumman Corporation's shareholders approved all management-presented proposals, including the election of twelve directors, advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditor, while rejecting a shareholder proposal on executive clawback policy at their 2025 Annual Meeting.
NYSE
Northrop Grumman reports a decrease in first quarter 2025 earnings due to a loss provision on the B-21 program, despite a record backlog of $92.8 billion.
NYSE
Northrop Grumman's Board of Directors approved 2025 executive compensation plans, including incentive plan goals and RPSR/RSR awards, and announced the departure of director Graham Robinson.
NYSE
Northrop Grumman reported strong 2024 financial results, meeting or exceeding company-level financial guidance, with a record backlog of $91.5 billion and a 4.4 percent increase in sales.
NYSE
Northrop Grumman announced a 2% increase in third-quarter sales to $10.0 billion, alongside a 13% rise in diluted earnings per share to $7.00, and has raised its full-year guidance.
NYSE
Northrop Grumman has finalized the compensation package for its incoming Chief Financial Officer, Kenneth Crews, who will assume the role on October 1, 2024.
NYSE
Northrop Grumman's second quarter 2024 results show a 7% increase in sales and a 19% increase in diluted earnings per share, leading to an increased full-year guidance.
NYSE
Northrop Grumman's shareholders approved the 2024 Long-Term Incentive Stock Plan and an amendment to the company's charter eliminating certain officer liabilities at the annual meeting on May 15, 2024.
NYSE
Northrop Grumman has announced several executive leadership changes, including a new CFO and presidents for Mission Systems and Defense Systems, while reaffirming its 2024 financial guidance.
NYSE
Northrop Grumman's first quarter 2024 results show a 9% increase in sales and a 15% increase in diluted earnings per share, driven by strong performance and cost efficiencies.
NYSE
Northrop Grumman's board has approved 2024 incentive plans for named executive officers, focusing on cash flow, operating income, and shareholder return.
NYSE
Northrop Grumman has successfully issued $2.5 billion in senior notes across three tranches to fund general corporate purposes.
NYSE
Northrop Grumman has announced the pricing of a $2.5 billion underwritten public offering of senior unsecured notes to be used for general corporate purposes.
NYSE
Northrop Grumman's Q4 results show a 6% sales increase and a record backlog of $84.2 billion, but were impacted by a $1.56 billion pre-tax charge related to the B-21 program.